Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT00281060
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic peripheral artery disease Rutherford stages 3 to 5
* \>50% stenosis of the ipsilateral superficial femoral artery
* Lesion length \>30mm
* At least one patent crural run-off vessel,
Exclusion Criteria:
* Acute criticla limb ischemia
* Previous ipsilateral bypass surgery or ipsilateral SFA stenting
* Untreated inflow disease
* Known intolerance to clopidogrel, aspirin or radiocontrast
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00281060
Study Brief:
Protocol Section:
NCT00281060